Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / DCGO - Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In DocGo To Contact Him Directly To Discuss Their Options | Benzinga


DCGO - Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In DocGo To Contact Him Directly To Discuss Their Options | Benzinga

  • If you purchased or acquired securities in DocGo between November 8, 2022 and September 17, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/DCGO.

    There is no cost or obligation to you.


    NEW YORK, Nov. 04, 2023 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DocGo Inc. ("DocGo" or the "Company") (NASDAQ:DCGO) and reminds investors of the December 26, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

    Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.

    As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) DocGo's executive hiring processes were inadequate to fully review and vet the professional and academic backgrounds of job candidates; (2) the foregoing increased the likelihood of disruptive executive turnover; (3) contrary to its representations to investors, DocGo had overstated the efficacy of its mobile health and medical transportation services, the very services contemplated by the Relocation Contract; (4) all of the foregoing, once revealed, was likely to subject DocGo to significant reputational and/or regulatory scrutiny that would negatively impact the Company's financial position and/or prospects; and (5) as a result, the Company's public statements were materially false and misleading at all relevant times.

    In November 2022, DocGo announced that Defendant Anthony Capone ("Capone") would be succeeding Defendant Stan Vashovsky ("Vashovsky") as Chief Executive Officer ("CEO") effective January 1, 2023. In a press release detailing the leadership transition, Defendant Vashovsky was quoted stating, in relevant part, "[w]e are very fortunate to have someone with [Defendant Capone's] skill set and track record ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: DocGo Inc.
    Stock Symbol: DCGO
    Market: NASDAQ
    Website: docgo.com

    Menu

    DCGO DCGO Quote DCGO Short DCGO News DCGO Articles DCGO Message Board
    Get DCGO Alerts

    News, Short Squeeze, Breakout and More Instantly...